Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Optimal Dose Finding Study of N-Acetylcysteine in Patients With Myeloproliferative Neoplasms

NCT05123365 is registered in ClinicalTrials.gov with University of California, Irvine as lead sponsor.

NCT NCT05123365
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05123365 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Optimal Dose Finding Study of N-Acetylcysteine in Patients With Myeloproliferative Neoplasms
Lead sponsor
University of California, Irvine
Phase
Phase 1/2
Overall status
Recruiting
Start date
January 3, 2022
Completion date
November 15, 2026
Enrollment
27 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

essential thrombocythemia, mpn, myelofibrosis, myeloproliferative neoplasm, polycythemia vera